Fig. 6From: Human targeted phenobarbital presents a poor substrate of gut microbiome deciphering new drug targets beyond pharmacokinetic curbsPrincipal component analysis (PCA) of different attributes observed for post phenobarbital oral treatment (15Â mg/kg of body weight) at different transit times in the small intestineBack to article page